QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 244 filers reported holding QIAGEN NV in Q3 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,331,810 | -16.3% | 847,699 | -6.9% | 2.58% | -7.6% |
Q2 2023 | $40,996,123 | +31.1% | 910,418 | +33.7% | 2.80% | +46.6% |
Q1 2023 | $31,275,942 | -0.8% | 680,948 | +7.7% | 1.91% | +2.3% |
Q4 2022 | $31,525,021 | +21.8% | 632,144 | +0.8% | 1.87% | +17.6% |
Q3 2022 | $25,890,000 | -12.3% | 627,169 | +0.3% | 1.59% | -13.4% |
Q2 2022 | $29,508,000 | -28.0% | 625,173 | -25.3% | 1.83% | -5.6% |
Q1 2022 | $40,983,000 | -31.5% | 836,392 | -22.3% | 1.94% | -28.8% |
Q4 2021 | $59,804,000 | -13.6% | 1,076,007 | -19.6% | 2.72% | -16.7% |
Q3 2021 | $69,182,000 | +20.6% | 1,338,662 | +12.9% | 3.27% | +19.3% |
Q2 2021 | $57,355,000 | +41.2% | 1,185,510 | +42.1% | 2.74% | +23.9% |
Q1 2021 | $40,618,000 | +19.0% | 834,208 | +29.2% | 2.21% | +13.6% |
Q4 2020 | $34,122,000 | +37.8% | 645,634 | +36.2% | 1.95% | +16.2% |
Q3 2020 | $24,767,000 | +7.8% | 473,926 | -30.3% | 1.68% | -21.6% |
Q4 2019 | $22,976,000 | +177.7% | 679,775 | +170.9% | 2.14% | +137.7% |
Q3 2019 | $8,274,000 | – | 250,950 | – | 0.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |